Atlas Trials

Radiofrequency Ablation Combined With Recombinant Human Adenovirus Type 5 in the Treatment of Hepatocellular Carcinoma.

Clinical trial NCT03790059 · UNKNOWN

Trial details

NCT number
NCT03790059
Sponsor
Southwest Hospital, China
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Hepatocellular Carcinoma
Start date
2016-10-01
Primary completion
2020-09-01
Enrollment
160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.